SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $907,235 | -22.8% | 261,451 | +3.4% | 0.00% | – |
| Q2 2023 | $1,175,605 | +5.9% | 252,818 | +5.2% | 0.00% | – |
| Q1 2023 | $1,109,927 | -42.5% | 240,244 | +0.6% | 0.00% | – |
| Q4 2022 | $1,928,736 | +123.0% | 238,705 | +53.1% | 0.00% | – |
| Q3 2022 | $865,000 | +21.1% | 155,873 | +13.8% | 0.00% | – |
| Q2 2022 | $714,000 | -42.3% | 136,983 | -9.1% | 0.00% | – |
| Q1 2022 | $1,238,000 | -44.4% | 150,618 | +0.7% | 0.00% | – |
| Q4 2021 | $2,226,000 | -29.4% | 149,615 | -10.3% | 0.00% | -100.0% |
| Q3 2021 | $3,153,000 | +10.4% | 166,879 | +8.6% | 0.00% | 0.0% |
| Q2 2021 | $2,856,000 | +23.7% | 153,596 | +51.5% | 0.00% | – |
| Q1 2021 | $2,308,000 | +5.4% | 101,398 | +0.6% | 0.00% | – |
| Q4 2020 | $2,189,000 | +254.8% | 100,815 | +64.3% | 0.00% | – |
| Q3 2020 | $617,000 | +59.4% | 61,363 | +23.0% | 0.00% | – |
| Q2 2020 | $387,000 | +31.2% | 49,905 | +73.0% | 0.00% | – |
| Q1 2020 | $295,000 | -6.9% | 28,854 | +0.1% | 0.00% | – |
| Q4 2019 | $317,000 | +21.0% | 28,838 | 0.0% | 0.00% | – |
| Q3 2019 | $262,000 | -24.5% | 28,838 | -5.4% | 0.00% | – |
| Q2 2019 | $347,000 | +105.3% | 30,472 | +104.8% | 0.00% | – |
| Q1 2019 | $169,000 | – | 14,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |